(VIANEWS) – Shares of TherapeuticsMD (NASDAQ: TXMD) fell 8.47% to $8.65 at 15:36 EST on Wednesday, after five successive sessions in a row of gains. NASDAQ is rising 2.66% to $12,677.84, after two sequential sessions in a row of losses. This seems, up until now, an all-around bullish trend exchanging session today.
TherapeuticsMD’s last close was $9.45, 82.17% under its 52-week high of $53.00.
Today’s last reported volume for TherapeuticsMD is 367788 which is 76.08% below its average volume of 1537802.
TherapeuticsMD’s sales growth is a negative 9.6% for the present quarter and 24.1% for the next. The company’s growth estimates for the ongoing quarter and the next is 27.3% and 50%, respectively.
Year-on-year quarterly revenue growth declined by 17.3%, now sitting on 86.95M for the twelve trailing months.
TherapeuticsMD’s last week, last month’s, and last quarter’s current intraday variation average was a positive 20.88%, a negative 0.74%, and a positive 7.80%, respectively.
TherapeuticsMD’s highest amplitude of average volatility was 20.88% (last week), 11.31% (last month), and 7.80% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
TherapeuticsMD’s stock is considered to be oversold (<=20).
TherapeuticsMD’s Stock Yearly Top and Bottom Value
TherapeuticsMD’s stock is valued at $8.65 at 15:36 EST, way below its 52-week high of $53.00 and way above its 52-week low of $1.99.
TherapeuticsMD’s Moving Average
TherapeuticsMD’s value is way higher than its 50-day moving average of $7.30 and way below its 200-day moving average of $17.44.
More news about TherapeuticsMD (TXMD).